Cathinone derivatives, pharmaceutical formulations, and methods
US11912705B2 · kind B2 · utility
0Cited by
0References
42Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 20, 2021 |
| Grant date | Feb 27, 2024 |
| Priority date | — |
| Expiry date | Oct 16, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/18
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds, such as cathinone derivatives, and pharmaceutical formulations that include the compounds. The compounds may have a first selectivity for a first receptor subtype that is at least 10 times greater than a second selectivity for a second receptor subtype from the same class of receptors. Methods of treating patients, which may include administering to a patient a pharmaceutical formulation that includes a compound, such as a cathinone derivative.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.